
Quick Links |
|
Join Our List
|
How itchy is your dog? |  |
Learn where to download a validated scale to measure canine pruritus severity
|

 Blog
| |
|
Had a good month thanks to itchy pets? Give back by making a donation to the ACVD Research Fund
|
|
|
|
 |
Greetings and Happy New Year!
Do you grow tired of ivory-tower recommendations that don't make sense to you or your clients? For years you were advised to rely on antihistamines for canine atopic dermatitis when it was apparent to most of us that they provided a very marginal benefit (since confirmed). Now you are asked to perform allergy testing, although you know that (a) the tests don't agree with one another and (b) there is no real evidence that one testing method is better than the others. (If you doubt me on the first point, try sending in duplicate samples to more than one lab on your next allergy patient!) I take pride in offering my clients a practical, evidence-based approach to managing atopic dermatitis, which I outline in this issue.
2012 was an exciting year for SkinVet, with RESPIT sales more than doubling over 2011. Would you help us grow in the new year by telling some colleagues about RESPIT? They'll save 50% on their first order of RESPIT Injectable placed before February 28, 2013 by using the coupon code below. Based on our experience, we are confident that they will continue to prescribe RESPIT in the future. Our challenge is spreading awareness with less than a seven figure marketing budget.
Please take a moment to forward this newsletter to a several friends and let them know how RESPIT has helped you in your practice of veterinary dermatology!
--Jon Plant, DVM, DACVD |
A Practical, 3-Step Approach to Canine Atopic Dermatitis
|
Step 1: Determine if CAD is the likely diagnosis using a validated checklist available here. Step 2: Investigate and rule out alternative or concurrent diagnoses based on the clinical findings.
Finding
|
Rule out
|
Diagnostic Plan
|
Dorso-lumbar distribution
|
Flea allergy dermatitis
|
Therapeutic trial with Comfortis® or Trifexis®
|
Ear margin or lateral elbow distribution
|
Sarcoptes
|
Superficial skin scrapings
Therapeutic trial
|
Dorsal trunk scale or crust
|
Cheyletiella
|
Superficial skin scraping
Tape impression
Trichogram
|
Comedones, follicular plugging
|
Demodicosis
|
Deep skin scrapings
|
Epidermal collarettes, pustules, lichenification
|
Pyoderma,
Malassezia dermatitis
|
Skin surface cytology
|
Pinnal erythema
|
Otitis externa
|
Ear canal cytology
|
Unusual presentation, poor therapeutic response, late-onset
|
Cutaneous T-cell lymphoma
|
Skin biopsy Dermatopathology
|
Step 3: Intervene early in the course of the disease, with evidence-based medicine. - The long-term plan: Immunotherapy to reduce or eliminate the need for short-term and rescue medications. RESPIT, regionally-specific immunotherapy, is a practical alternative to allergy-test based immunotherapy.
- The short-term plan: Atopica® or prednisone, if needed for initial patient comfort or rescue from an allergy flare-up.
- Topical therapy: Regular bathing may help remove allergens and aid in the control of pyoderma or Malassezia dermatitis. Topical cortisone sprays can help with spot treatment.
|
Veterinary Dermatology Research
|
Background: The third iteration of the Canine Atopic Dermatitis Extent and Severity Index (CADESI-03) is the only tool rigorously validated for canine atopic dermatitis (CAD) lesion scoring. The CADESI-03 requires 248 evaluations, limiting its widespread use. Hypothesis/Objectives: The goal of the study was to develop and validate a practical method of grading CAD lesions that requires scoring only the frequently affected body regions. Animals: Fifty-seven privately owned atopic dogs were used in the study. Methods: The Canine Atopic Dermatitis Lesion Index (CADLI) was evaluated in an open, multicentre reliability study. Validity was assessed with expert opinion (content validity) and comparison of CADLI with existing disease severity measures (construct and criterion validity). Reliability was evaluated by analysing repeated observations of each dog. Convenience was assessed in terms of the time required to complete the scale.
read more. |
Visit us at the NAVC in Orlando
| We will be in the Orlando World Center Marriott, booth 4127, ready to answer your questions! |
|
SkinVet Clinic serves the dermatological needs of pets throughout Oregon and Washington. In the course of his practice, Dr. Plant developed RESPIT and has made it available to veterinarians across the US, together with the manufacturer, NelcoVet (US Vet Lic #359).
Jon Plant, DVM, DACVD SkinVet Clinic, LLC 15800 SW Upper Boones Ferry Rd. #120 Lake Oswego, OR 97035 www.skinvetclinic.com www.vetrespit.com 503-352-3376
"If we knew what it was we were doing, it would not be called research, would it?" -- Albert Einstein |
|
|